Our website is made possible by displaying online advertisements to our visitors.
Please consider supporting us by disabling your ad blocker.
ATC code D05
| ATC code D: Dermatologicals |
|---|
|
| ATCvet only |
| Other ATC codes |
ATC code D05 Antipsoriatics is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup D05 is part of the anatomical group D Dermatologicals.[4]
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QD05.[5]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
In ATCvet, this subgroup is named "QD05 Drugs for keratoseborrheic disorders".
- ^ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
- ^ World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
- ^ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
- ^ "ATC/DDD Index 2022: code D05". WHO Collaborating Centre for Drug Statistics Methodology.
- ^ "ATCvet Index 2022: code QD05". WHO Collaborating Centre for Drug Statistics Methodology.
Previous Page Next Page
